Intellectus Partners, LLC Immatics N.V. Transaction History
Intellectus Partners, LLC
- $394 Million
- Q1 2025
A detailed history of Intellectus Partners, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Intellectus Partners, LLC holds 15,500 shares of IMTX stock, worth $70,060. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,500Holding current value
$70,060% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
82.1MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$47.9 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$42.4 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$32.9 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$29.6 Million0.76% of portfolio
-
Vestal Point Capital, LP New York, NY6.28MShares$28.4 Million2.65% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $345M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...